Paper18544439
New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting.
Lee NY and 1 other. Semin Oncol, 2008. Cited by 30 papers, by iCite.
Cite this record
ConductScience Library. New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting. Papers, record 18544439. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18544439
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Squamous Cell | Major topic |
| Cell Hypoxia | Major topic |
| Head and Neck Neoplasms | Major topic |
| Radiotherapy, Intensity-Modulated | Major topic |
| Advance Care Planning | |
| Biomarkers | |
| Forecasting | |
| Humans | |
| Treatment Outcome |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| P01 CA067166 | NCI NIH HHS | United States | P01CA067166 | PubMed and NIH | NIH RePORTER |
| R01 CA118582 | NCI NIH HHS | United States | R01CA118582 | PubMed and NIH | NIH RePORTER |
| 1 R01 CA118582-01 | NCI NIH HHS | United States | R01CA118582 | PubMed and NIH | NIH RePORTER |
References132
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17390721 | Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers. | Radiat Res | 2007 | https://conductscience.org/library/papers/17390721 | PubMed |
| 2 | 11849800 | ARCON: experience in 215 patients with advanced head-and-neck cancer. | Int J Radiat Oncol Biol Phys | 2002 | https://conductscience.org/library/papers/11849800 | PubMed |
| 3 | 17028293 | Do erythropoietin receptors on cancer cells explain unexpected clinical findings? | J Clin Oncol | 2006 | https://conductscience.org/library/papers/17028293 | PubMed |
| 4 | 17493769 | Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. | Int J Radiat Oncol Biol Phys | 2007 | https://conductscience.org/library/papers/17493769 | PubMed |
| 5 | 17161557 | Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experience. | Int J Radiat Oncol Biol Phys | 2007 | https://conductscience.org/library/papers/17161557 | PubMed |
| 6 | 8996152 | Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials. | J Clin Oncol | 1997 | https://conductscience.org/library/papers/8996152 | PubMed |
| 7 | 17523848 | Bystander effects of bioreductive drugs: potential for exploiting pathological tumor hypoxia with dinitrobenzamide mustards. | Radiat Res | 2007 | https://conductscience.org/library/papers/17523848 | PubMed |
| 8 | 10749120 | Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. | Cancer Res | 2000 | https://conductscience.org/library/papers/10749120 | PubMed |
| 9 | 11516874 | Forward or inversely planned segmental multileaf collimator IMRT and sequential tomotherapy to treat multiple dominant intraprostatic lesions of prostate cancer to 90 Gy. | Int J Radiat Oncol Biol Phys | 2001 | https://conductscience.org/library/papers/11516874 | PubMed |
| 10 | 11439212 | Improvements in target coverage and reduced spinal cord irradiation using intensity-modulated radiotherapy (IMRT) in patients with carcinoma of the thyroid gland. | Radiother Oncol | 2001 | https://conductscience.org/library/papers/11439212 | PubMed |
| 11 | 17606726 | Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104. | Clin Cancer Res | 2007 | https://conductscience.org/library/papers/17606726 | PubMed |
| 12 | 10691731 | Loss of PTEN facilitates HIF-1-mediated gene expression. | Genes Dev | 2000 | https://conductscience.org/library/papers/10691731 | PubMed |
| 13 | 15590175 | Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. | Int J Radiat Oncol Biol Phys | 2004 | https://conductscience.org/library/papers/15590175 | PubMed |
| 14 | 16358297 | Intensity-modulated radiation therapy in head and neck cancers: an update. | Head Neck | 2007 | https://conductscience.org/library/papers/16358297 | PubMed |
| 15 | 10974465 | Dose optimization for the treatment of anaplastic thyroid carcinoma: a comparison of treatment planning techniques. | Int J Radiat Oncol Biol Phys | 2000 | https://conductscience.org/library/papers/10974465 | PubMed |
| 16 | 10766193 | Detection of hypoxia in human squamous cell carcinoma by EF5 binding. | Cancer Res | 2000 | https://conductscience.org/library/papers/10766193 | PubMed |
| 17 | 17145527 | A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinoma. | Int J Radiat Oncol Biol Phys | 2006 | https://conductscience.org/library/papers/17145527 | PubMed |
| 18 | 9510041 | A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. | Radiother Oncol | 1998 | https://conductscience.org/library/papers/9510041 | PubMed |
| 19 | 986241 | Hypoxia-dependent reduction of 1-(2-nitro-1-imidazolyl)-3-methoxy-2-propanol by Chinese hamster ovary cells and KHT tumor cells in vitro and in vivo. | Cancer Res | 1976 | https://conductscience.org/library/papers/986241 | PubMed |
| 20 | 10640954 | Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma. | Cancer | 2000 | https://conductscience.org/library/papers/10640954 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40653801 | Clinical feasibility of atlas-based auto-segmentation for organ-at-risk contouring in head-and-neck radiotherapy. | J Appl Clin Med Phys | 2025 | https://conductscience.org/library/papers/40653801 | PubMed |
| 39144264 | Radiation induced brachial plexopathy in head and neck cancer patients treated with definitive radiotherapy and correlation with disease characteristics and dosimetric parameters. | Rep Pract Oncol Radiother | 2024 | https://conductscience.org/library/papers/39144264 | PubMed |
| 39136231 | Vocal Fold Medialization Procedures in Previously Radiated Patients: A Survey of Practice Patterns. | Laryngoscope | 2025 | https://conductscience.org/library/papers/39136231 | PubMed |
| 35910347 | The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35910347 | PubMed |
| 33632902 | Radiation therapy in head and neck cancer. | Saudi Med J | 2021 | https://conductscience.org/library/papers/33632902 | PubMed |
| 32084217 | The role of Glial cell derived neurotrophic factor in head and neck cancer. | PLoS One | 2020 | https://conductscience.org/library/papers/32084217 | PubMed |
| 29335337 | Salivary glands regenerate after radiation injury through SOX2-mediated secretory cell replacement. | EMBO Mol Med | 2018 | https://conductscience.org/library/papers/29335337 | PubMed |
| 28249612 | Do selective radiation dose escalation and tumour hypoxia status impact the loco-regional tumour control after radio-chemotherapy of head & neck tumours? The ESCALOX protocol. | Radiat Oncol | 2017 | https://conductscience.org/library/papers/28249612 | PubMed |
| 25036711 | Neurotrophic factor GDNF promotes survival of salivary stem cells. | J Clin Invest | 2014 | https://conductscience.org/library/papers/25036711 | PubMed |
| 24829856 | Relationship between head and neck cancer therapy and some genetic endpoints. | World J Clin Oncol | 2014 | https://conductscience.org/library/papers/24829856 | PubMed |
| 24203760 | Final results of a phase II single-institutional trial with hyperfractionated radiation therapy (HFX) and four-weekly continuous cisplatin in locally advanced head and neck carcinoma. | Clin Transl Oncol | 2014 | https://conductscience.org/library/papers/24203760 | PubMed |
| 23812668 | A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth. | Clin Cancer Res | 2013 | https://conductscience.org/library/papers/23812668 | PubMed |
| 23188186 | Volumetric intensity-modulated arc therapy vs conventional intensity-modulated radiation therapy in nasopharyngeal carcinoma: a dosimetric study. | J Radiat Res | 2013 | https://conductscience.org/library/papers/23188186 | PubMed |
| 22300574 | Radiation dose to the brachial plexus in head-and-neck intensity-modulated radiation therapy and its relationship to tumor and nodal stage. | Int J Radiat Oncol Biol Phys | 2012 | https://conductscience.org/library/papers/22300574 | PubMed |
| 21998334 | A novel aldehyde dehydrogenase-3 activator leads to adult salivary stem cell enrichment in vivo. | Clin Cancer Res | 2011 | https://conductscience.org/library/papers/21998334 | PubMed |
| 21838917 | Concurrent image-guided intensity modulated radiotherapy and chemotherapy following neoadjuvant chemotherapy for locally advanced nasopharyngeal carcinoma. | Radiat Oncol | 2011 | https://conductscience.org/library/papers/21838917 | PubMed |
| 20706842 | Photodynamic therapy of early stage oral cavity and oropharynx neoplasms: an outcome analysis of 170 patients. | Eur Arch Otorhinolaryngol | 2011 | https://conductscience.org/library/papers/20706842 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18544439
GET https://conductscience.org/api/papers/v1/18544439/references?page=2